Sirolimus, Tacrolimus, and rabbit ATG (r-ATG) as Graft-Versus-Host Disease Prophylaxis in Patients Undergoing Unrelated Donor Peripheral Blood Hematopoietic Cell Transplant (HCT): Extended Follow Up and Updated Analysis

Authors :: Ji-Lian Cai
A P Nademanee
Vinod Pullarkat
David S. Snyder
Joycelynne Palmer
Samer K. Khaled
Ryotaro Nakamura
S.J. Forman
David Senitzer
Pablo M. Parker
Source :: Biology of Blood and Marrow Transplantation. 17:S330
Publication Year :: 2011
Publisher :: Elsevier BV, 2011.

Subjects :: Transplantation
Hematopoietic cell
business.industry
Hematology
medicine.disease
Tacrolimus
Peripheral blood
Graft-versus-host disease
Unrelated Donor
Sirolimus
Immunology
Medicine
In patient
Rabbit ATG
business
medicine.drug

Full Text Access

Tools